Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 688 | 38 | 0.2120 | 0.3835 | 0.0552 | 0.0574 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 973 | 157 | 0.2661 | 0.4331 | 0.1614 | 0.1398 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 1459 | 185 | 0.4155 | 0.4331 | 0.1268 | 0.1398 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 2180 | 286 | 0.6177 | 0.4331 | 0.1312 | 0.1398 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 832 | 108 | 0.2361 | 0.2764 | 0.1298 | 0.1279 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 969 | 132 | 0.2730 | 0.2764 | 0.1362 | 0.1279 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 1112 | 131 | 0.3200 | 0.2764 | 0.1178 | 0.1279 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 1778 | 219 | 0.5085 | 0.3290 | 0.1232 | 0.1295 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 1096 | 139 | 0.3121 | 0.3290 | 0.1268 | 0.1295 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 592 | 82 | 0.1663 | 0.3290 | 0.1385 | 0.1295 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 1033 | 143 | 0.2903 | 0.2489 | 0.1384 | 0.1284 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 1051 | 139 | 0.2975 | 0.2489 | 0.1323 | 0.1284 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 550 | 63 | 0.1588 | 0.2489 | 0.1145 | 0.1284 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 839 | 282 | 0.1817 | 0.3021 | 0.3361 | 0.3372 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1465 | 510 | 0.3115 | 0.3021 | 0.3481 | 0.3372 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 1884 | 617 | 0.4132 | 0.3021 | 0.3275 | 0.3372 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 511 | 140 | 0.1210 | 0.1227 | 0.2740 | 0.2535 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 508 | 135 | 0.1217 | 0.1227 | 0.2657 | 0.2535 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 494 | 109 | 0.1256 | 0.1227 | 0.2206 | 0.2535 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1809 | 601 | 0.3940 | 0.2445 | 0.3322 | 0.3329 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 1072 | 372 | 0.2283 | 0.2445 | 0.3470 | 0.3329 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 501 | 160 | 0.1112 | 0.2445 | 0.3194 | 0.3329 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 447 | 138 | 0.1008 | 0.1000 | 0.3087 | 0.3467 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 488 | 174 | 0.1024 | 0.1000 | 0.3566 | 0.3467 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 475 | 178 | 0.0969 | 0.1000 | 0.3747 | 0.3467 |